Sign in
4

Changes in Ownership

CorMedix Inc. Filed Acc 0001213900-20-012013

Options or other derivatives

  • EVP, Head of Clinical Ops. acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Masson-Hurlburt Elizabeth · EVP, Head of Clinical Ops.

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-05-11 Grant or award : show line 1 in the form Stock Option (Right to Buy Common Stock) +37,500 $5.63 $211,125 $5.63 2030-05-11 37,500 37,500 D
2020-05-11 Grant or award : show line 2 in the form Stock Option (Right to Buy Common Stock) +37,500 $4.08 $153,000 $4.08 2030-05-11 37,500 37,500 D
Loading xslF345X03/doc4.xml…